Tyra Biosciences, Inc. Ttl Offset Amt
Tyra Biosciences, Inc. (TYRA) had Ttl Offset Amt of $0 as of 2026-09-14, per its 424B5 filed 2026-09-15.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-09-15
- 2026-09-14: Ttl Offset Amt $0.00.
- 2026-09-11: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-09-14 | $0.00 424B5 · filed 2026-09-15 |
| 2026-09-11 | $0.00 S-3ASR · filed 2026-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |